Corporate

Corporate Industry Technology Medical Updates

MoyoAssist® Recognized as One of the “2025 Suzhou Top Ten Industrial Scientific and Technological Achievements”

Driving Forward Innovation in Surgical MCS: Insights from the magAssist Short-to-Mid Term Circulatory Support Seminar

Redefining New Boundaries in Delivering Patient Care

magAssist Recognized in 2024 VENTURE50 Awards

Corporate
magAssist Shortlisted for 2025 Prix Galien USA Best Start-Up Award 2025-08-14
Corporate
MoyoAssist® Recognized as One of the “2025 Suzhou Top Ten Industrial Scientific and Technological Achievements” 2025-07-24
Corporate
Driving Forward Innovation in Surgical MCS: Insights from the magAssist Short-to-Mid Term Circulatory Support Seminar 2025-04-08
Corporate
Redefining New Boundaries in Delivering Patient Care 2025-01-24
Corporate
magAssist Recognized in 2024 VENTURE50 Awards 2025-01-09
Corporate
magAssist was included in the catalogue of "Advantageous Enterprises in the Fourth Batch of Intellectual Property Strong Companies Cultivation Project in Suzhou City". 2024-12-20
Corporate
MoyoAssist® Launched! The Mid-to-Short-Term MCS Forum and Extra-VAD Clinical Technology Transformation Results Conference Successfully Held 2024-06-24
Corporate
NMPA grants approval to MoyoAssist® China's first full maglev extracorporeal VAD 2024-05-14
Corporate
magAssist ECMO approved in the Transformation of Scientific and Technological Achievements Special Fund 2023-08-28
Corporate
magAssist Attains Recognition as the Most Innovative Medical Device Product of 2023 2023-08-21

Tags： Prix Galien, Award, Technological, Awards, Seminar, Surgical MCS, Innovation, U.S. FDA, Interventional Ventricular Assist Device, Breakthrough Device,